GlassScriptPhysician profile
Brian D Ballard
NPI 1952892796
$15,498.74
in general payments reported to CMS, 2019-2025
36 companies · $7,624 in 2025
The $7,624 reported for 2025 was more than what 98% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $40.32 · 2021: $355 · 2022: $1,426 · 2023: $3,852 · 2024: $2,202 · 2025: $7,624.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $9,048 · Travel and Lodging: $2,960 · Grant: $1,500 · Education: $170.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $9,048.17 |
| Travel and Lodging | $2,959.73 |
| Grant | $1,500.00 |
| Education | $170.24 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $7,461.15 | 2022-2025 | Optis, Prostar, Aveir |
| Kestra Medical Technology Services, INC. | $1,966.39 | 2023-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $693.38 | 2021-2025 | Lifevest |
| Shockwave Medical, INC | $688.49 | 2022-2025 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Inari Medical, INC. | $672.93 | 2021-2025 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Boston Scientific Corporation | $549.60 | 2023-2025 | Watchman Access System, Watchman Flx, Ranger |
| Stryker Corporation | $424.73 | 2025 | Flowtriever, Clottriever Bold Catheter, Flowtriever Catheter, S |
| Abiomed | $307.01 | 2022-2025 | Impella |
| Philips North America LLC | $288.74 | 2022-2025 | Eagle Eye, (5044) Mcot |
| Edwards Lifesciences Corporation | $285.54 | 2022-2025 | Edwards Sapien 3 Ultra Transcatheter Heart Valve, Sapien 3 Ultra Resilia |
| Janssen Pharmaceuticals, INC | $244.23 | 2021-2024 | Xarelto |
| E.R. Squibb & Sons, L.L.C. | $161.88 | 2022-2023 | Camzyos |
| Cardiovascular Systems INC. | $160.28 | 2021 | |
| Cardiva Medical, INC. | $157.88 | 2023-2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Boehringer Ingelheim Pharmaceuticals, INC. | $155.50 | 2023-2024 | Jardiance |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $141.90 | 2025 | Indigo System |
| Angiodynamics, INC. | $141.24 | 2023 | Alphavac |
| Amgen INC. | $121.55 | 2022-2024 | Repatha |
| Actelion Pharmaceuticals US, INC. | $103.27 | 2023 | Opsumit, Uptravi |
| Kiniksa Pharmaceuticals, LTD. | $100.97 | 2022-2023 | Arcalyst |
| Novartis Pharmaceuticals Corporation | $83.12 | 2022-2024 | |
| Heartflow, INC. | $80.00 | 2023 | Ffrct |
| Terumo Medical Corporation | $56.16 | 2022-2024 | Angio-Seal |
| Chiesi USA, INC. | $51.38 | 2024-2025 | Kengreal, Cleviprex |
| Teleflex LLC | $47.39 | 2025 | Turnpike, Guideliner |
| Surmodics, INC. | $47.37 | 2025 | Pounce Thrombectomy System, Pounce Venous Thrombectomy System, Sublime Microcatheter, 018, 200cm, Straight |
| Alnylam Pharmaceuticals INC. | $42.93 | 2022-2025 | Onpattro |
| Sanofi-Aventis U.S. LLC | $40.32 | 2020 | |
| Imperative Care, INC | $39.96 | 2025 | Symphony Catheter |
| Daiichi Sankyo INC. | $34.55 | 2022-2023 | Injectafer |
| Scpharmaceuticals INC. | $34.48 | 2023 | |
| Pfizer INC. | $33.72 | 2022-2023 | |
| Medtronic, INC. | $30.19 | 2025 | Symplicity G3 |
| Cordis US Corp. | $17.51 | 2023 | Zephyr |
| Merck Sharp & Dohme LLC | $17.44 | 2024 | Verquvo |
| Kiniksa Pharmaceuticals International, Plc | $15.56 | 2024 | Arcalyst |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brian Ballard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.